Loncar Cancer Immunotherapy ETF Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (34)

Latest Posts

About This Stock More About This Stock
5 ETFs Riding High On The Biotech Comeback
Article By: Sweta Killa
Saturday, July 9, 2022 10:57 PM EST
The high-growth biotech segment has borne the maximum brunt of the broader market sell-off.
In this article: XBI, BBC, BBP, SBIO, CNCR
Read
5 ETFs Jump After Three-Day Rout: Will The Rally Last?
Article By: Sweta Killa
Thursday, September 10, 2020 11:58 AM EST
Here are the ETFs that were at the forefront of the market rebound on Sep 9 and will continue to do so if market sentiments remain positive.
In this article: PBW, PTH, ARKQ, CNCR, FNGS Also: AZN, AAPL, MSFT, TSLA
Read
Moderna ETFs To Gain On New Positive COVID-19 Vaccine Data
Article By: Zacks Investment Research
Friday, August 28, 2020 6:31 PM EST
The competition to come up with a coronavirus vaccine is opening up near-term opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide exposure to Moderna.
In this article: IBB, BBH, XBI, MRNA, CNCR, BTEC, IDNA, GERM
Read
Moderna - A Step Closer To Coronavirus Vaccine: ETFs To Gain
Article By: Zacks Investment Research
Sunday, June 14, 2020 3:44 PM EST
The first company to start human clinical trials of its coronavirus vaccine candidate in the United States — Moderna — has informed that it is on schedule to initiate the final-stage clinical trial by July.
In this article: AZN, JNJ, BBH, MRNA, CNCR, IDNA Also: IBB, XBI
Read
3 ETFs For More Moderna Bets
Article By: Benzinga
Tuesday, May 19, 2020 10:50 AM EST
Shares of biotechnology company Moderna Inc jumped 20% Monday on news that its mRNA-1273 coronavirus vaccine candidate is making positive progress.
In this article: CNCR, BTEC, IDNA, MRNA
Read

Latest Tweets for $CNCR

No tweets yet!

PARTNER HEADLINES